RecentMedicalFindings.com
Summarizing relevant biomedical research!
mast cell sarcoma     Bookmark and Share
Search webpages of this site (RecentMedicalFindings):
Didn't find what you wanted? Try it at BioMedLib™ !
Search directly on the biomedical articles using BioMedLib™ search engine:



1. Biomedical articles (top 50; 2009 to 2014)
1. |||||||||. 100%  Fujimoto A, Wada Y, Kanada T, Ishikawa Y, Kadota K: Mast cell sarcoma with megakaryocytic differentiation in a calf. J Vet Med Sci; 2012 Dec;74(12):1643-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma with megakaryocytic differentiation in a calf.
  • A case of mast cell sarcoma in a 5-month-old Holstein female calf is described.
  • Macroscopically, enlargement of the spleen, lymph nodes, tonsils and kidneys was noted, and there were tumor masses in the neck region and on the pleura and peritoneum.
  • The pericardium and uterine and ureter walls were also involved by tumor.
  • Some of the predominant type of these tumor cells were found within the epithelia of the lungs, tonsils, gastrointestinal tract, liver, ureters, urinary bladder and uterus.
  • [MeSH-major] Cattle Diseases / pathology. Mast-Cell Sarcoma / veterinary. Megakaryocytes / pathology. Tumor Markers, Biological / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22813945.001).
  • [ISSN] 1347-7439
  • [Journal-full-title] The Journal of veterinary medical science / the Japanese Society of Veterinary Science
  • [ISO-abbreviation] J. Vet. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Naphthols; 0 / Tumor Markers, Biological; 35245-26-2 / naphthol AS-D chloroacetate; 9001-27-8 / Factor VIII; EC 3.1.- / Esterases; EC 3.4.21.59 / Tryptases
  •  go-up   go-down


2. |||||||||. 97%  Ryan RJ, Akin C, Castells M, Wills M, Selig MK, Nielsen GP, Ferry JA, Hornick JL: Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications. Mod Pathol; 2013 Apr;26(4):533-43
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications.
  • Mast cell sarcoma is a rare, aggressive neoplasm composed of cytologically malignant mast cells presenting as a solitary mass.
  • Previous descriptions of mast cell sarcoma have been limited to single case reports, and the pathologic features of this entity are not well known.
  • Here, we report three new cases of mast cell sarcoma and review previously reported cases.
  • Mast cell sarcoma has a characteristic morphology of medium-sized to large epithelioid cells, including bizarre multinucleated cells, and does not closely resemble either normal mast cells or the spindle cells of systemic mastocytosis.
  • None of our three cases were correctly diagnosed as mast cell neoplasms on initial pathological evaluation, suggesting that this entity may be under-recognized.
  • Molecular testing of mast cell sarcoma has not thus far detected the imatinib-resistant KIT D816V mutation, suggesting that recognition of these cases may facilitate specific targeted therapy.
  • [MeSH-major] Mast-Cell Sarcoma / pathology

  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23196796.001).
  • [ISSN] 1530-0285
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


3. ||||...... 40%  Georgin-Lavialle S, Aguilar C, Guieze R, Lhermitte L, Bruneau J, Fraitag S, Canioni D, Chandesris MO, Suarez F, Grandpeix-Guyodo C, Damaj G, Barete S, Aouba A, Fite C, Robert C, Gaulard P, Lortholary O, Tournilhac O, Dubreuil P, Hermine O: Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature. J Clin Oncol; 2013 Feb 20;31(6):e90-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma: a rare and aggressive entity--report of two cases and review of the literature.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Mast-Cell Sarcoma / diagnosis. Mast-Cell Sarcoma / drug therapy
  • [MeSH-minor] Adult. Antigens, CD30 / metabolism. Fatal Outcome. Genotype. Humans. Immunohistochemistry. Interleukin-2 Receptor alpha Subunit / metabolism. Male. Mast Cells / drug effects. Mast Cells / metabolism. Mast Cells / pathology. Proto-Oncogene Proteins c-kit / genetics. Proto-Oncogene Proteins c-kit / metabolism

  • ResearchGate. author profiles.
  • The Weizmann Institute of Science GeneCards and MalaCards databases. gene/protein/disease-specific - MalaCards for mast-cell sarcoma .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23129735.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD30; 0 / Interleukin-2 Receptor alpha Subunit; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


Advertisement
4. |......... 4%  Bautista-Quach MA, Ake CD, Chen M, Wang J: Gastrointestinal lymphomas: Morphology, immunophenotype and molecular features. J Gastrointest Oncol; 2012 Sep;3(3):209-25
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of these, the two most frequently encountered histologic subtypes are extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma), where Helicobacter pylori infection is implicated in a number of cases, and diffuse large B cell lymphoma.
  • Several B cell lymphomas are associated with chromosomal aberrations.
  • Enteropathy-associated T cell lymphoma, type I in particular, usually arises in a background of celiac disease.
  • T cell gene rearrangement confirms clonality.
  • NK/T cell neoplasms are invariably associated with Epstein-Barr virus infection and are often aggressive; thus, differentiation from a benign NK-cell enteropathy is paramount.
  • Although incidence of other hematopoietic malignancies in the gastrointestinal tract such as plasma cell myeloma associated with amyloidosis, plasmablastic lymphoma, Hodgkin disease, histiocytic sarcoma and mast cell sarcoma is extremely rare, these entities have been documented, with the latter two demonstrating aggressive clinical behavior.
  • Endoscopic ultrasonography is an important adjunct in disease staging and follow-up.
  • Conservative antibiotic treatment of stage I MALT lymphomas with associated Helicobacter pylori infection achieves good clinical outcome with high remission rate.

  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] World J Gastroenterol. 2009 Dec 7;15(45):5746-50 [19960575.001]
  • [Cites] Am J Surg Pathol. 2004 Sep;28(9):1133-44 [15316312.001]
  • [Cites] Clin Gastroenterol Hepatol. 2010 Oct;8(10):A20 [20601139.001]
  • [Cites] Blood. 2011 Feb 3;117(5):1447-52 [20966166.001]
  • [Cites] J Cancer Res Ther. 2010 Jul-Sep;6(3):342-3 [21119271.001]
  • [Cites] Mediterr J Hematol Infect Dis. 2009;1(2):e2009030 [21416007.001]
  • [Cites] Am J Surg Pathol. 2011 Aug;35(8):1195-203 [21716086.001]
  • [Cites] Am J Surg Pathol. 2011 Sep;35(9):1255-63 [21836483.001]
  • [Cites] Pediatr Surg Int. 2012 Mar;28(3):267-70 [21969235.001]
  • [Cites] Srp Arh Celok Lek. 2011 Jul-Aug;139(7-8):523-6 [21980666.001]
  • [Cites] Hum Pathol. 2004 Oct;35(10):1285-8 [15492998.001]
  • [Cites] Mod Pathol. 2005 May;18(5):693-704 [15696128.001]
  • [Cites] J Clin Oncol. 2005 Sep 10;23(26):6370-8 [16155022.001]
  • [Cites] J Natl Cancer Inst. 2005 Sep 21;97(18):1345-53 [16174856.001]
  • [Cites] Am J Surg Pathol. 2006 Oct;30(10):1274-80 [17001159.001]
  • [Cites] Leukemia. 2007 Mar;21(3):389-96 [17230229.001]
  • [Cites] Clin Cancer Res. 2007 Sep 1;13(17):5124-32 [17785567.001]
  • [Cites] Am J Gastroenterol. 2008 Mar;103(3):776-87 [18076735.001]
  • [Cites] Curr Opin Gastroenterol. 2008 Sep;24(5):623-6 [19122505.001]
  • [Cites] Minerva Chir. 2009 Apr;64(2):229-33 [19365324.001]
  • [Cites] Appl Immunohistochem Mol Morphol. 2009 Mar;17(2):172-7 [19521280.001]
  • [Cites] Korean J Gastroenterol. 2009 Sep;54(3):174-9 [19844154.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2010 Feb;24(1):27-34 [20206106.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2010 Feb;24(1):43-56 [20206108.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2010 Feb;24(1):71-7 [20206110.001]
  • [Cites] J Clin Invest. 2010 Jun;120(6):2131-43 [20440074.001]
  • [Cites] J Gastrointest Cancer. 2012 Jun;43(2):379-81 [20703830.001]
  • [Cites] Histopathology. 2011 Jan;58(1):49-68 [21261683.001]
  • [Cites] J Immunol. 2011 Jun 1;186(11):6165-72 [21518972.001]
  • [Cites] J Clin Pathol. 2011 Nov;64(11):1035-7 [21778298.001]
  • [Cites] Virchows Arch. 2011 Nov;459(5):495-502 [22002677.001]
  • [Cites] Pathol Res Pract. 2011 Dec 15;207(12):786-9 [22078056.001]
  • [Cites] Acta Gastroenterol Belg. 2011 Sep;74(3):451-3 [22103053.001]
  • [Cites] Mod Pathol. 1999 Jul;12(7):739-43 [10430280.001]
  • [Cites] Am J Gastroenterol. 2002 Feb;97(2):292-7 [11866264.001]
  • [Cites] Gut. 2002 May;50 Suppl 3:III19-24 [11953328.001]
  • [Cites] Surg Endosc. 2003 Mar;17(3):469-74 [12404054.001]
  • [Cites] Ann Oncol. 2003 Apr;14(4):623-9 [12649111.001]
  • [Cites] Pathol Res Pract. 2004;200(6):473-8 [15310151.001]
  • [Cites] Genes Chromosomes Cancer. 2005 Nov;44(3):247-55 [16049916.001]
  • [Cites] Am J Surg Pathol. 2005 Dec;29(12):1633-41 [16327436.001]
  • [Cites] Ann Hematol. 2006 Dec;85(12):849-56 [16944146.001]
  • [Cites] Mod Pathol. 2007 Mar;20(3):310-9 [17277765.001]
  • [Cites] Crit Rev Oncol Hematol. 2007 Jul;63(1):65-71 [17339119.001]
  • [Cites] Diagn Pathol. 2012;7:16 [22333190.001]
  • [Cites] J Gastroenterol Hepatol. 2012 Mar;27(3):617 [22353350.001]
  • [Cites] Am J Gastroenterol. 2008 Jan;103(1):62-70 [17894851.001]
  • [Cites] Ann Oncol. 2008 Dec;19(12):1992-9 [18647965.001]
  • [Cites] Surg Endosc. 2009 Oct;23(10):2191-6 [19118429.001]
  • [Cites] Leuk Lymphoma. 2009 Mar;50(3):335-40 [19255922.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2009;23(5):671-8 [19744632.001]
  • [Cites] Gastrointest Endosc. 2010 Mar;71(3):655-7 [19879569.001]
  • [Cites] Blood. 2011 Dec 1;118(23):6018-22 [21984805.001]
  • [Cites] Am J Surg Pathol. 2002 Feb;26(2):216-24 [11812943.001]
  • [Cites] Cancer. 2003 Feb 1;97(3):586-91 [12548600.001]
  • [Cites] Gastroenterology. 2003 Sep;125(3):730-45 [12949719.001]
  • [Cites] J Gastroenterol. 2003;38(10):921-9 [14614598.001]
  • [Cites] N Engl J Med. 2004 Jan 15;350(3):239-48 [14724303.001]
  • [Cites] Ann Surg. 2004 Jul;240(1):28-37 [15213615.001]
  • [Cites] Gastrointest Endosc. 2010 Apr;71(4):851-5 [20363431.001]
  • (PMID = 22943012.001).
  • [ISSN] 2219-679X
  • [Journal-full-title] Journal of gastrointestinal oncology
  • [ISO-abbreviation] J Gastrointest Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  • [Other-IDs] NLM/ PMC3418529
  • [Keywords] NOTNLM ; Gastrointestinal lymphomas / MALT lymphoma / NK/T-cell enteropathy
  •  go-up   go-down


5. |......... 6%  Cooper IF, Siadaty MS: 'Neoplastic Processes' associated with 'Malignant Mast Cell Tumor Clinical': Top Publications. BioMedLib Review; NeoplasticProcess;MalignantMastCell:706992504. ISSN: 2331-5717. 2014/4/3
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Neoplastic Processes' associated with 'Malignant Mast Cell Tumor Clinical': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Neoplastic Process' for 'malignant mast cell tumor clinical'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Neoplastic Process'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 26 publications, and group two 6740 publications.
  • Here are the top 10.
  • Brcić L et al: Mast-cell sarcoma of the tibia.
  • Lin TY et al: The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors.
  • Heller DA et al: Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.
  • Ryan RJ et al: Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications.
  • Fujimoto A et al: Mast cell sarcoma with megakaryocytic differentiation in a calf.
  • Baselmans AH et al: Brief communication, Histopathology of a spontaneously developing mast cell sarcoma in a Wistar rat.
  • Baker-Gabb M et al: Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
  • Ma HB et al: Successful treatment of mast cell sarcoma of the uterus with imatinib.
  • Raymond JT et al: Malignant mast cell tumor in an African hedgehog (Atelerix albiventris).
  • Kim YS et al: Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706992504.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


6. |......... 1%  Carlsten KS, London CA, Haney S, Burnett R, Avery AC, Thamm DH: Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors. J Vet Intern Med; 2012 Jan-Feb;26(1):135-41
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.
  • BACKGROUND: Mast cell tumors (MCT) are common cutaneous tumors in dogs and when not amenable to surgical excision can present a therapeutic challenge.
  • METHODS: Prospective clinical trial.
  • CONCLUSIONS AND CLINICAL IMPORTANCE: The combination of hypofractionated RT, toceranib, and prednisone was tolerated and efficacious in the majority of dogs.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Dog Diseases / drug therapy. Dog Diseases / radiotherapy. Mast-Cell Sarcoma / veterinary. Skin Neoplasms / veterinary
  • [MeSH-minor] Animals. DNA, Neoplasm / chemistry. DNA, Neoplasm / genetics. Disease-Free Survival. Dogs. Female. Indoles / administration & dosage. Kaplan-Meier Estimate. Male. Polymerase Chain Reaction / veterinary. Prednisone / administration & dosage. Prospective Studies. Proto-Oncogene Proteins c-kit / genetics. Pyrroles / administration & dosage

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • HSDB. structure - PYRROLE.
  • HSDB. structure - PREDNISONE.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 by the American College of Veterinary Internal Medicine.
  • [Cites] Eur J Cancer. 2008 Nov;44(16):2506-17 [18723339.001]
  • [Cites] Eur J Cancer. 2009 Jan;45(2):228-47 [19097774.001]
  • [Cites] Clin Cancer Res. 2009 Jun 1;15(11):3856-65 [19470739.001]
  • [Cites] Vet Anaesth Analg. 2008 Jul;35(4):355-62 [18466168.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1207-16 [19545786.001]
  • [Cites] Cancer. 2009 Aug 1;115(15):3571-80 [19536893.001]
  • [Cites] J Radiat Res. 2004 Dec;45(4):557-61 [15635266.001]
  • [Cites] Neoplasia. 2006 Feb;8(2):104-11 [16611403.001]
  • [Cites] Vet Pathol. 2007 May;44(3):298-308 [17491070.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 2008 Jul 1;71(3):873-9 [18514780.001]
  • [Cites] Top Companion Anim Med. 2009 Aug;24(3):106-12 [19732728.001]
  • [Cites] J Vet Pharmacol Ther. 2010 Apr;33(2):162-71 [20444041.001]
  • [Cites] Am J Vet Res. 2002 Dec;63(12):1718-23 [12492288.001]
  • [Cites] Clin Cancer Res. 2003 Jul;9(7):2755-68 [12855656.001]
  • [Cites] Cancer Res. 2003 Jul 15;63(14):4009-16 [12873999.001]
  • [Cites] Adv Vet Sci Comp Med. 1970;14:309-54 [4922146.001]
  • [Cites] J Am Vet Med Assoc. 1970 Dec 1;157(11):1707-12 [4991973.001]
  • [Cites] Vet Clin North Am. 1974 Nov;4(4):889-96 [4216135.001]
  • [Cites] J Natl Cancer Inst. 1979 Sep;63(3):691-4 [112313.001]
  • [Cites] Br Vet J. 1986 Jan-Feb;142(1):1-19 [3947927.001]
  • [Cites] J Am Vet Med Assoc. 1988 Oct 15;193(8):936-40 [3142828.001]
  • [Cites] J Vet Intern Med. 1994 Nov-Dec;8(6):406-8 [7884726.001]
  • [Cites] Cornell Vet. 1964 Oct;54:517-9 [14234055.001]
  • (PMID = 22176473.001).
  • [ISSN] 1939-1676
  • [Journal-full-title] Journal of veterinary internal medicine / American College of Veterinary Internal Medicine
  • [ISO-abbreviation] J. Vet. Intern. Med.
  • [Language] eng
  • [Grant] United States / NCI NIH HHS / CA / P30 CA016058; United States / NCRR NIH HHS / RR / UL1 RR025755; United States / NCATS NIH HHS / TR / UL1 TR000090
  • [Publication-type] Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Indoles; 0 / Pyrroles; 24F9PF7J3R / toceranib phosphate; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; VB0R961HZT / Prednisone
  • [Other-IDs] NLM/ NIHMS522752; NLM/ PMC3837098
  •  go-up   go-down


7. |......... 7%  Cooper IF, Siadaty MS: 'Cells' associated with 'Malignant Mast Cell Tumor Clinical': Top Publications. BioMedLib Review; Cell;MalignantMastCell:706968987. ISSN: 2331-5717. 2014/1/3
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Cells' associated with 'Malignant Mast Cell Tumor Clinical': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Cell' for 'malignant mast cell tumor clinical'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Cell'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 28 publications, and group two 3646 publications.
  • Here are the top 10.
  • Brcić L et al: Mast-cell sarcoma of the tibia.
  • Ryan RJ et al: Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications.
  • Fujimoto A et al: Mast cell sarcoma with megakaryocytic differentiation in a calf.
  • Heller DA et al: Assessment of cyclooxygenase-2 expression in canine hemangiosarcoma, histiocytic sarcoma, and mast cell tumor.
  • Lin TY et al: The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors.
  • Baselmans AH et al: Brief communication, Histopathology of a spontaneously developing mast cell sarcoma in a Wistar rat.
  • Ma HB et al: Successful treatment of mast cell sarcoma of the uterus with imatinib.
  • Chott A et al: Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma.
  • Baker-Gabb M et al: Soft tissue sarcomas and mast cell tumours in dogs; clinical behaviour and response to surgery.
  • Weiler CR et al: Mast cell sarcoma: clinical management.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706968987.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


8. |......... 2%  Monteiro B, Boston S, Monteith G: Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs. Can Vet J; 2011 Nov;52(11):1209-14
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.
  • The recommended treatment for soft tissue sarcomas (STS) and mast cell tumors (MCT) is complete surgical removal, provided that the tumor is amenable to surgical excision.
  • Decreased body weight was a risk factor (P = 0.03, odd's ratio = 0.96) as well as increased tumor size (1.4% increase in risk of incomplete excision per cm(2); P = 0.02).
  • Gender, age, breed, location, grade, tumor type, re-excision, and level of surgeon's training (P = 0.0711) were not significant.
  • [MeSH-major] Dog Diseases / surgery. Mast-Cell Sarcoma / veterinary. Sarcoma / veterinary

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bull World Health Organ. 1974;50(1-2):79-100 [4547652.001]
  • [Cites] Aust Vet J. 1979 Dec;55(12):602-4 [231964.001]
  • [Cites] J Bone Joint Surg Am. 1989 Mar;71(3):370-5 [2925710.001]
  • [Cites] Semin Vet Med Surg (Small Anim). 1986 Feb;1(1):72-83 [3148990.001]
  • [Cites] J Am Vet Med Assoc. 1992 Sep 15;201(6):873-8 [1383179.001]
  • [Cites] J Clin Oncol. 1996 Feb;14(2):473-8 [8636760.001]
  • [Cites] J Am Vet Med Assoc. 1997 Nov 1;211(9):1147-51 [9364229.001]
  • [Cites] J Am Vet Med Assoc. 2005 Apr 15;226(8):1368-74 [15844431.001]
  • [Cites] J Vet Diagn Invest. 2005 May;17(3):245-8 [15945380.001]
  • [Cites] J Am Anim Hosp Assoc. 2005 Jul-Aug;41(4):241-6 [15995161.001]
  • [Cites] J Am Vet Med Assoc. 2005 Nov 1;227(9):1442-8 [16279389.001]
  • [Cites] J Am Vet Med Assoc. 2006 Jan 1;228(1):91-5 [16426175.001]
  • [Cites] J Am Vet Med Assoc. 2006 Jan 15;228(2):210-5 [16426187.001]
  • [Cites] J Am Vet Med Assoc. 2007 Feb 15;230(4):548-54 [17302554.001]
  • [Cites] Vet Pathol. 2007 May;44(3):335-41 [17491075.001]
  • [Cites] J Small Anim Pract. 2007 Aug;48(8):424-31 [17559522.001]
  • [Cites] Jpn J Clin Oncol. 2008 Oct;38(10):701-9 [18845523.001]
  • [Cites] Vet Surg. 2008 Jul;37(5):461-5 [18986313.001]
  • [Cites] J Vet Intern Med. 2008 Nov-Dec;22(6):1373-9 [18976288.001]
  • [Cites] Vet Pathol. 2009 Mar;46(2):362-4, author reply 364-5 [19261652.001]
  • [Cites] Vet Pathol. 2009 Sep;46(5):928-33 [19429989.001]
  • [Cites] J Am Vet Med Assoc. 2000 Jul 15;217(2):205-10 [10909459.001]
  • [Cites] J Am Vet Med Assoc. 2001 Apr 1;218(7):1120-3 [11318363.001]
  • [Cites] J Am Anim Hosp Assoc. 2002 Jan-Feb;38(1):71-3 [11804319.001]
  • [Cites] J Vet Med A Physiol Pathol Clin Med. 2002 Mar;49(2):87-91 [11958472.001]
  • [Cites] J Am Anim Hosp Assoc. 2002 Sep-Oct;38(5):458-66 [12220031.001]
  • [Cites] J Am Vet Med Assoc. 2004 Jan 15;224(2):236-40 [14736068.001]
  • [Cites] Aust Vet J. 2003 Dec;81(12):732-8 [15080482.001]
  • [Cites] Vet Rec. 2004 Jun 12;154(24):743-6 [15224593.001]
  • [Cites] J Small Anim Pract. 1973 Jan;14(1):27-41 [4199921.001]
  • [Cites] Cancer Res. 1974 Nov;34(11):2859-68 [4529096.001]
  • [Cites] Vet Pathol. 1984 Sep;21(5):469-74 [6435301.001]
  • [Cites] Aust Vet J. 1987 Jun;64(6):161-4 [3115242.001]
  • (PMID = 22547841.001).
  • [ISSN] 0008-5286
  • [Journal-full-title] The Canadian veterinary journal. La revue vétérinaire canadienne
  • [ISO-abbreviation] Can. Vet. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Canada
  • [Other-IDs] NLM/ PMC3196013
  •  go-up   go-down


9. |||||||||. 116%  Falleti J, Borgia L, Lalinga AV, De Cecio R, Natella V, Patitucci G, Vita G: Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis? Pathol Res Pract; 2012 Nov 15;208(11):683-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?
  • Mastocytosis is a neoplastic disease of mast cells and their CD34+ precursors, including a heterogeneous group of disorders.
  • It is characterized by abnormal growth and accumulation of mast cells in one or more organ systems.
  • Mast cell sarcoma is an extremely rare and aggressive disease characterized by local proliferation of atypical mast cells, destructive growth and poor prognosis, without systemic involvement.
  • Very few clinical cases describing this entity have been reported in the literature.
  • In this paper, we report a case of a mast cell sarcoma, localized in the scalp of a 63-year-old woman; it appears to be the first manifestation of undisclosed systemic mastocytosis.
  • [MeSH-major] Head and Neck Neoplasms / diagnosis. Mast Cells / pathology. Mast-Cell Sarcoma / diagnosis. Mastocytosis, Systemic / diagnosis. Scalp. Skin Neoplasms / diagnosis
  • [MeSH-minor] DNA Mutational Analysis. DNA, Neoplasm / analysis. Diagnosis, Differential. Female. Humans. Middle Aged. Mutation. Proto-Oncogene Proteins c-kit / genetics. Proto-Oncogene Proteins c-kit / metabolism. Tumor Markers, Biological / metabolism

  • Genetic Alliance. consumer health - Mast cell disease.
  • Genetic Alliance. consumer health - Systemic mastocytosis.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2012 Elsevier GmbH. All rights reserved.
  • (PMID = 22963840.001).
  • [ISSN] 1618-0631
  • [Journal-full-title] Pathology, research and practice
  • [ISO-abbreviation] Pathol. Res. Pract.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Tumor Markers, Biological; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


10. |||||||||. 115%  Weiler CR, Butterfield J: Mast cell sarcoma: clinical management. Immunol Allergy Clin North Am; 2014 May;34(2):423-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma: clinical management.
  • Mast cell sarcoma is a disorder that results in abnormal mast cells as identified by morphology, special stains, and in some publications, c-kit mutation analysis.
  • In humans it is a very rare condition, with variable clinical presentation.
  • There is no standard therapy for the disorder.
  • The prognosis of mast cell sarcoma in published literature is very poor in humans.

  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2014 Elsevier Inc. All rights reserved.
  • (PMID = 24745684.001).
  • [ISSN] 1557-8607
  • [Journal-full-title] Immunology and allergy clinics of North America
  • [ISO-abbreviation] Immunol Allergy Clin North Am
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Clinical presentation of mast cell sarcoma / Mast cell sarcoma / Mastocytosis / Prognosis of mast cell sarcoma / Treatment of mast cell sarcoma
  •  go-up   go-down


11. |||||||||. 106%  Ma HB, Xu X, Liu WP, Chang H, Zeng F, Wang YC: Successful treatment of mast cell sarcoma of the uterus with imatinib. Int J Hematol; 2011 Nov;94(5):491-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of mast cell sarcoma of the uterus with imatinib.
  • Mast cell sarcoma is a rare disease characterized by localized, but destructive and rapid, growth of the tumor, high risk of distant metastasis, possibility of a leukemic phase, and poor prognosis.
  • We report successful treatment of uterine mast cell sarcoma with imatinib in a 39-year-old woman who presented with abdominal distention and massive ascites.
  • We administered imatinib to the patient and achieved a good response in the absence of c-kit mutation, BCR/ABL, and FIP1L1-PDGFRα.
  • Our results indicate that imatinib is of potential use in the treatment of mast cell sarcoma.
  • [MeSH-major] Antineoplastic Agents / administration & dosage. Mast-Cell Sarcoma / drug therapy. Mast-Cell Sarcoma / genetics. Piperazines / administration & dosage. Pyrimidines / administration & dosage. Uterine Neoplasms / drug therapy. Uterine Neoplasms / genetics

  • Genetics Home Reference. consumer health - FIP1L1 Gene.
  • MedlinePlus Health Information. consumer health - Uterine Cancer.
  • HSDB. structure - IMATINIB MESYLATE.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22020400.001).
  • [ISSN] 1865-3774
  • [Journal-full-title] International journal of hematology
  • [ISO-abbreviation] Int. J. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Benzamides; 0 / FIP1L1-PDGFRA fusion protein, human; 0 / Oncogene Proteins, Fusion; 0 / Piperazines; 0 / Pyrimidines; 0 / mRNA Cleavage and Polyadenylation Factors; BKJ8M8G5HI / imatinib; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 2.7.10.1 / Receptor, Platelet-Derived Growth Factor alpha
  •  go-up   go-down


12. |||||||||. 85%  Auquit-Auckbur I, Lazar C, Deneuve S, Guillemet C, Cordel N, Blanchard F, Joly P, Courville P: Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma. Am J Surg Pathol; 2012 May;36(5):779-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
  • Mastocytosis is a group of disorders characterized by abnormal mast cell proliferation, involving the skin in 80% of cases.
  • Mast cell sarcomas, part of the systemic forms of mastocytosis, are very rare tumors characterized by a destructive growth of highly atypical mast cells, with secondary spread, poor prognosis, and low survival rates.
  • We report the first known case of primary cutaneous mast cell sarcoma due to the transformation of a benign solitary mastocytoma in an adult suffering from an unregressive localized cutaneous mastocytosis.
  • Histologic characteristics of the tumor, mutation analysis, and c-Kit expression were compared with available data.
  • Wide surgical excision of the tumor followed by adjuvant local radiotherapy were performed, and for the first time the use of imatinib was attempted, as neoplastic mast cells expressed the CD117 marker.
  • However, they failed to control the progression of sarcoma.
  • To date, no treatment is known to be effective for this disease, which is associated with short-term survival of the patients.
  • [MeSH-major] Cell Transformation, Neoplastic. Mast-Cell Sarcoma / pathology. Mastocytoma, Skin / pathology. Skin Neoplasms / pathology


13. ||||||||.. 75%  Bautista-Quach MA, Booth CL, Kheradpour A, Zuppan CW, Rowsell EH, Weiss L, Wang J: Mast cell sarcoma in an infant: a case report and review of the literature. J Pediatr Hematol Oncol; 2013 May;35(4):315-20
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma in an infant: a case report and review of the literature.
  • Mast cell diseases comprise a spectrum of disorders including cutaneous mastocytosis, indolent or aggressive systemic variants including leukemia, and unifocal tumor formations such as benign extracutaneous mastocytoma or aggressive mast cell sarcoma (MCS).
  • Many mast cell diseases are associated with aberrancy of c-KIT proto-oncogene resulting in tyrosine kinase activity, typically exhibiting point mutation in codon 816.
  • MCS is an exceedingly rare clinicopathologic entity characterized by a unifocal accumulation of neoplastic mast cells that grow in a locally destructive manner.
  • We report a case in a 2-year-old boy who was initially diagnosed at 8 months of age with atypical cutaneous mastocytoma of the right ear with subsequent aggressive, destructive growth pattern; features that were most consistent with MCS.
  • So far, MCS has been documented in the literature in at least 6 human cases.
  • To the best of our knowledge, our case represents the first MCS in an infant.
  • [MeSH-major] Mast-Cell Sarcoma / diagnosis

  • ExactAntigen/Labome. author profiles.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23211696.001).
  • [ISSN] 1536-3678
  • [Journal-full-title] Journal of pediatric hematology/oncology
  • [ISO-abbreviation] J. Pediatr. Hematol. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


14. |||||||... 73%  Kim YS, Wu H, Pawlowska AB, Bautista-Quach MA, Huang Q, Gaal K, Chang KL: Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm. Am J Surg Pathol; 2013 Mar;37(3):453-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pediatric mast cell sarcoma of temporal bone with novel L799F (2395 C>T) KIT mutation, mimicking histiocytic neoplasm.
  • Mast cell sarcoma (MCS) is an extremely rare neoplasm with a clinically aggressive course.
  • Because of its rarity, its morphologic and molecular characteristics are still not well defined.
  • We report a case of a 15-year-old girl with MCS of the temporal bone extending into the posterior fossa creating a mass effect.
  • The KIT D816V mutation is frequently found in systemic mastocytosis, but it has not been documented in the few reported human MCS cases.
  • However, 1 reported case of MCS has shown a different alteration in the KIT gene.
  • Our case is the first MCS case with L799F mutation, located between the catalytic loop (790 to 797) and the activation loop (810 to 837) of the KIT gene, and only the second case of MCS with KIT mutation documented in the literature.
  • [MeSH-major] Bone Neoplasms / diagnosis. Bone Neoplasms / genetics. Histiocytic Sarcoma / diagnosis. Mast-Cell Sarcoma / diagnosis. Mast-Cell Sarcoma / genetics. Mutation, Missense. Proto-Oncogene Proteins c-kit / genetics
  • [MeSH-minor] Adolescent. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Combined Modality Therapy. DNA Mutational Analysis. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Radiotherapy. Temporal Bone / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23388130.001).
  • [ISSN] 1532-0979
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


15. |||||..... 52%  Schwaab J, Horny HP, Jonescheit J, Metzgeroth G, Schafhausen P, Gaiser T, Marx A, Kienle P, Hofmann WK, Reiter A: Mast cell sarcoma mimicking metastatic colon carcinoma. Ann Hematol; 2014 Jun;93(6):1067-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma mimicking metastatic colon carcinoma.
  • [MeSH-major] Adenocarcinoma / diagnosis. Colonic Neoplasms / diagnosis. Liver Neoplasms / diagnosis. Mast-Cell Sarcoma / diagnosis. Neoplasms, Second Primary / diagnosis
  • [MeSH-minor] Aged. Colon / chemistry. Colon / pathology. Eosinophils / pathology. Female. Gastrointestinal Hemorrhage / etiology. Humans. Hypereosinophilic Syndrome. Liver / chemistry. Liver / pathology. Mast Cells / pathology. Mastocytosis, Systemic. Neoplasms, Multiple Primary. Tumor Markers, Biological

  • MedlinePlus Health Information. consumer health - Liver Cancer.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24141335.001).
  • [ISSN] 1432-0584
  • [Journal-full-title] Annals of hematology
  • [ISO-abbreviation] Ann. Hematol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Tumor Markers, Biological
  •  go-up   go-down


16. ||||...... 39%  Bugalia A, Abraham A, Balasubramanian P, Srivastava A, Nair S: Mast cell sarcoma of the small intestine: a case report. J Clin Pathol; 2011 Nov;64(11):1035-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell sarcoma of the small intestine: a case report.
  • [MeSH-major] Bone Neoplasms / pathology. Laryngeal Neoplasms / ultrastructure. Mast-Cell Sarcoma / pathology. Mast-Cell Sarcoma / ultrastructure. Tibia

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Clin Pathol. 2007 Apr;60(4):424-5 [17405977.001]
  • [CommentOn] J Clin Pathol. 1986 Jun;39(6):596-602 [3088063.001]
  • (PMID = 21778298.001).
  • [ISSN] 1472-4146
  • [Journal-full-title] Journal of clinical pathology
  • [ISO-abbreviation] J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Comment; Journal Article
  • [Publication-country] England
  •  go-up   go-down


17. |......... 7%  Su XY, Xu X, Tang Y, Li GD: [Diagnosis of hematolymphoid malignancy by using effusion fluid cytology specimens: a study of 33 cases]. Zhonghua Bing Li Xue Za Zhi; 2009 Aug;38(8):542-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnosis of hematolymphoid malignancy by using effusion fluid cytology specimens: a study of 33 cases].
  • OBJECTIVE: To study the diagnostic accuracy of hematolymphoid malignancy by using effusion fluid cytology specimens and to evaluate the values of immunocytochemistry for this assay.
  • METHODS: The cytospin preparations/smears and cell block sections of effusion cytology specimens from 33 cases of hematolymphoid malignancy were retrospectively reviewed.
  • In selected cases, in-situ hybridization for Epstein-Barr virus-encoded RNA and immunoglobulin and T-cell receptor gene rearrangement study were carried out as indicated.
  • RESULTS: There were 33 cases of hematolymphoid malignancy, including 12 cases of T-lymphoblastic leukemia/lymphoma, 16 cases of mature B cell neoplasm (including 9 cases of diffuse large B-cell lymphoma, 2 cases of Burkitt lymphoma, 2 cases of plasmacytoma/multiple myeloma, 2 cases of B-small lymphocytic leukemia/lymphoma and 1 case of mantle cell lymphoma), 3 cases of mature T or NK-cell neoplasm (including 1 case of extranodal nasal NK/T-cell lymphoma, 1 case of angioimmunoblastic T-cell lymphoma and 1 case of T-cell prolymphocytic leukemia), 1 case of myeloid sarcoma and 1 case of mast cell sarcoma.
  • Amongst the 33 cases studied, 16 represented disease relapses, including 8 cases of diffuse large B-cell lymphoma, 2 cases of plasmacytoma/multiple myeloma, 2 cases of B-small lymphocytic leukemia/lymphoma, 1 case of T-lymphoblastic leukemia/lymphoma, 1 case of angioimmunoblastic T-cell lymphoma, 1 case of mantle cell lymphoma and 1 case of mast cell sarcoma.
  • The remaining 17 cases showed serous effusion as the primary manifestation, with the diagnosis primarily made upon cytologic examination.
  • The cytologic findings seen in all the 33 cases studied were in agreement with the corresponding histologic diagnosis.
  • CONCLUSIONS: Diagnosis of hematolymphoid malignancy by effusion fluid cytology specimens is possible, especially when coupled with the clinical history, immunophenotype, in-situ hybridization and gene rearrangement study findings.
  • This is especially so for cases with disease relapses.
  • [MeSH-major] Ascitic Fluid / pathology. Cytodiagnosis / methods. Lymphoma, Large B-Cell, Diffuse / diagnosis. Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / diagnosis
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Burkitt Lymphoma / diagnosis. Burkitt Lymphoma / metabolism. Burkitt Lymphoma / pathology. Child. Female. Humans. Immunohistochemistry. Lymphoma, Extranodal NK-T-Cell / diagnosis. Lymphoma, Extranodal NK-T-Cell / metabolism. Lymphoma, Extranodal NK-T-Cell / pathology. Male. Middle Aged. Multiple Myeloma / diagnosis. Multiple Myeloma / metabolism. Multiple Myeloma / pathology. Plasmacytoma / diagnosis. Plasmacytoma / metabolism. Plasmacytoma / pathology. Retrospective Studies. Young Adult

  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20021966.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] China
  •  go-up   go-down


18. |......... 5%  Ozdemir D, Dagdelen S, Erbas T: Systemic mastocytosis. Am J Med Sci; 2011 Nov;342(5):409-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Systemic mastocytosis (SM) is a clonal disorder of hematopoietic system characterized by abnormal growth and accumulation of mast cells in various tissues.
  • Its clinical spectrum ranges from mild disease to an aggressive course with life-threatening conditions.
  • Some of the clinical signs or symptoms of SM (hyperhidrosis, syncope and hypotensive/tachycardiac attacks) require consideration of pheochromocytoma and carcinoid syndrome in the differential diagnosis.
  • The diagnosis relies on the demonstration of mast cell aggregates in bone marrow or extracutaneous tissues.
  • The World Health Organization categorizes SM into 6 variants: indolent SM, SM with associated clonal hematological nonmast cell lineage disease, aggressive SM, mast cell leukemia, mast cell sarcoma and extracutaneous mastocytosis.
  • [MeSH-major] Mastocytosis, Systemic / diagnosis. Mastocytosis, Systemic / pathology. Mastocytosis, Systemic / physiopathology
  • [MeSH-minor] Cell Lineage. Humans. Mast Cells / pathology. Mast Cells / physiology. Proto-Oncogene Proteins c-kit / genetics. Tryptases / blood. World Health Organization

  • Genetic Alliance. consumer health - Mast cell disease.
  • Genetic Alliance. consumer health - Systemic mastocytosis.
  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21629042.001).
  • [ISSN] 1538-2990
  • [Journal-full-title] The American journal of the medical sciences
  • [ISO-abbreviation] Am. J. Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] EC 2.7.10.1 / Proto-Oncogene Proteins c-kit; EC 3.4.21.59 / Tryptases
  •  go-up   go-down


19. |......... 5%  Andersen CL, Kristensen TK, Severinsen MT, Møller MB, Vestergaard H, Bergmann OJ, Hasselbalch HC, Bjerrum OW: Systemic mastocytosis--a systematic review. Dan Med J; 2012 Mar;59(3):A4397
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: The mast cell lives a hidden life, but it is implicated in several physiological reactions.
  • It is not until recent decades that the evolution of the cell has been described and its fascinating biology has only recently been depicted.
  • We here give a review of systemic mastocytosis in regards to cell biology, diagnostic approaches and clinical practice.
  • METHODS: A search was made in PubMed in August 2011 entering the keywords: mastocytosis, (systemic, cutaneous, aggressive), mast cell leukaemia, mast cell sarcoma, chromosome, mutation, haematology and treatment.
  • RESULTS: Mastocytosis is characterized by an abnormal proliferation of mast cells, which accumulate in one or several organ systems, primarily the skin and bone marrow.
  • The disease is clinically heterogeneous and varies from a relatively benign condition with isolated cutaneous lesions to a very aggressive systemic condition with a grave prognosis.
  • CONCLUSION: Patients with mastocytosis represent a heterogeneous group in terms of clinical presentation, management and prognosis.
  • [MeSH-major] Mast Cells / pathology. Mastocytosis, Systemic / pathology

  • Genetic Alliance. consumer health - Mast cell disease.
  • Genetic Alliance. consumer health - Systemic mastocytosis.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22381091.001).
  • [ISSN] 2245-1919
  • [Journal-full-title] Danish medical journal
  • [ISO-abbreviation] Dan Med J
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Glucocorticoids; 0 / Histamine Antagonists
  •  go-up   go-down


20. |......... 3%  Cooper IF, Siadaty MS: 'Hormones' associated with 'Disease Or Disorder Systemic Tissue Mast Cell': Top Publications. BioMedLib Review; Hormone;DiseaseOrDisorder:705165259. ISSN: 2331-5717. 2014/1/27
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Hormones' associated with 'Disease Or Disorder Systemic Tissue Mast Cell': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Hormone' for 'disease or disorder systemic tissue mast cell'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Hormone'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 23 publications, and group two 300 publications.
  • Here are the top 10.
  • Chan EC et al: KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells.
  • Morgado JM et al: Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.
  • Pozdnyakova O et al: High-sensitivity flow cytometric analysis for the evaluation of systemic mastocytosis including the identification of a new flow cytometric criterion for bone marrow involvement.
  • Pinto-Lopes P et al: Indolent systemic mastocytosis limited to the bone: a case report and review of the literature.
  • A Akbar S et al: Systemic mastocytosis presenting as acute appendicitis: a case report and review of the literature.
  • Sadashiv S et al: Use of octreotide for relief of gastro-intestinal (GI) symptoms in systemic mastocytosis.
  • Berezowska S et al: Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
  • Butterfield JH et al: Systemic mastocytosis in the elderly.
  • Moore AE et al: Systemic mastocytosis presenting with acute oliguric renal failure: report of a case and review of the literature.
  • Falleti J et al: Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705165259.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


21. |......... 3%  Cooper IF, Siadaty MS: 'Mammals' associated with 'Rat Sarcoma': Top Publications. BioMedLib Review; Mammal;RatSarcoma:706617582. ISSN: 2331-5717. 2014/9/29
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Mammals' associated with 'Rat Sarcoma': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Mammal' for 'rat sarcoma'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Mammal'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 21 publications, and group two 4230 publications.
  • Here are the top 10.
  • Kemmochi Y et al: Spontaneous histiocytic sarcoma of the popliteal lymph node in a young sprague-dawley rat.
  • Tinkey PT et al: Reliable establishment of human sarcoma xenografts in the nude rat.
  • Onozato T et al: Spontaneous Subcutaneous Sarcoma in a 50-week-old Male Wistar Hannover GALAS Rat.
  • Baselmans AH et al: Brief communication, Histopathology of a spontaneously developing mast cell sarcoma in a Wistar rat.
  • Bilello JA et al: Growth of murine sarcoma virus-transformed rat kidney cells in nude mice: absence of induction of host endogenous viruses.
  • Petrea I et al: [Homotransplantation in a Wistar rat of a metastasizing gastric fibroblastic sarcoma].
  • Van Andel RA et al: Splenic stromal myoid cell sarcoma in an aged F344 rat.
  • Rosenbaum MD et al: Solitary foot mass on a Sprague-Dawley rat. Cutaneous histiocytic sarcoma.
  • Smith BK et al: Experimental cachexia: effects of MCA sarcoma in the Fischer rat.
  • Sarma PS et al: A comparison of cat and rat cultures for the assay of woolly monkey sarcoma and related viruses.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706617582.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


22. |......... 3%  Cooper IF, Siadaty MS: 'Diseases or Syndromes' associated with 'Cutaneous Sarcoma': Top Publications. BioMedLib Review; DiseaseOrSyndrome;CutaneousSarcoma:707154199. ISSN: 2331-5717. 2014/10/5
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Diseases or Syndromes' associated with 'Cutaneous Sarcoma': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Disease or Syndrome' for 'cutaneous sarcoma'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Disease or Syndrome'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 32 publications, and group two 1502 publications.
  • Here are the top 10.
  • Stebbing J et al: The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma.
  • Lopes M et al: Cutaneous metastasis of bladder sarcoma: when should we consider this hypothesis? A review of the literature.
  • Grzegorzewska AE et al: Disseminated cutaneous Kaposi sarcoma in a patient receiving triptolide/tripdiolide for rheumatoid arthritis.
  • Berthaud V et al: Fatal unrecognized cutaneous and systemic Kaposi's sarcoma in an AIDS patient with acute cryptococcal meningoencephalitis.
  • Pamuk GE et al: Cutaneous Kaposi sarcoma which developed in a patient with aplastic anaemia using immunosuppressive therapy--description of the first adult case.
  • Orrock JM et al: INI1 and GLUT-1 expression in epithelioid sarcoma and its cutaneous neoplastic and nonneoplastic mimics.
  • Auquit-Auckbur I et al: Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
  • Ramdial PK et al: Cutaneous colesional acquired immunodeficiency syndrome associated Kaposi sarcoma and cryptococcosis.
  • Rosales CM et al: AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma.
  • Inhoff O et al: Disseminated cutaneous Kaposi sarcoma and progressive multifocal leukoencephalopathy in a patient with idiopathic CD4+ T lymphocytopenia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 707154199.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


23. |......... 3%  Cooper IF, Siadaty MS: 'Steroids' associated with 'Sarcoma Of Tibia': Top Publications. BioMedLib Review; Steroid;SarcomaOfTibia:705763075. ISSN: 2331-5717. 2014/4/27
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Steroids' associated with 'Sarcoma Of Tibia': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'steroid' for 'sarcoma of tibia'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'steroid'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 20 publications, and group two 558 publications.
  • Here are the top 10.
  • Brcić L et al: Mast-cell sarcoma of the tibia.
  • Beck SE et al: Intraosseous synovial sarcoma of the proximal tibia.
  • Kashima TG et al: Localized Ewing sarcoma of the tibia.
  • Ramseier LE et al: Allograft reconstruction for bone sarcoma of the tibia in the growing child.
  • Ozaki T et al: Reconstruction with ipsilateral fibula transfer with pasteurized bone after excision of bone sarcoma of the tibia.
  • Arkader A et al: Ewing sarcoma of the tibia mimicking fibrous dysplasia.
  • Kenan S et al: Case report 819: Periosteal Ewing's sarcoma of the tibia.
  • Ogihara Y et al: Limb salvage for bone sarcoma of the proximal tibia.
  • Agarwal N et al: Ewing's sarcoma of the calcaneus with metastases to the tibia and fibula.
  • Milgrom C et al: MRI and CT scan compared with microscopic histopathology in osteogenic sarcoma of the proximal tibia.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705763075.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


24. |......... 3%  Cooper IF, Siadaty MS: 'Neoplastic Processes' associated with 'Canine Diseases': Top Publications. BioMedLib Review; NeoplasticProcess;CanineDiseases:706761403. ISSN: 2331-5717. 2014/9/31
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Neoplastic Processes' associated with 'Canine Diseases': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Neoplastic Process' for 'canine diseases'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Neoplastic Process'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 16 publications, and group two 27243 publications.
  • Here are the top 9.
  • MULLIGAN RM: Neoplastic diseases of dogs; neoplasms of melanin-forming cells.
  • Strandberg JD et al: Animal model of human disease: canine mammary neoplasia.
  • Shin IS et al: Studies of cocktail therapy with multiple cytokines for neoplasia or infectious disease of the dog I. cDNA cloning of canine IL-3 and IL-6.
  • Chénier S et al: P-selectin expression in canine cutaneous inflammatory diseases and mast cell tumors.
  • MULLIGAN RM: Neoplastic diseases of dogs; mast cell sarcoma, lymphosarcoma, histiocytoma.
  • Sykes GP et al: Retrovirus-like particles associated with myeloproliferative disease in the dog.
  • Oyama MA et al: Clinical utility of serum N-terminal pro-B-type natriuretic peptide concentration for identifying cardiac disease in dogs and assessing disease severity.
  • Evans RJ et al: Myeloproliferative disease in the dog and cat: definition, aetiology and classification.
  • Guillon JC et al: [A focus of Aujeszky's disease in dogs in the department of Ain].

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706761403.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


25. |......... 3%  Cooper IF, Siadaty MS: 'Cells' associated with 'Body Of Uterus Sarcoma': Top Publications. BioMedLib Review; Cell;BodyOfUterus:706132852. ISSN: 2331-5717. 2014/6/23
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Cells' associated with 'Body Of Uterus Sarcoma': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Cell' for 'body of uterus sarcoma'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Cell'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 20 publications, and group two 336 publications.
  • Here are the top 10.
  • Murali Krishna C et al: Characterisation of uterine sarcoma cell lines exhibiting MDR phenotype by vibrational spectroscopy.
  • Greer DA et al: Distinct N-glycan glycosylation of P-glycoprotein isolated from the human uterine sarcoma cell line MES-SA/Dx5.
  • Kim SC et al: Successful treatment of a granulocytic sarcoma of the uterine cervix in complete remission at six-year follow-up.
  • Coley HM et al: Seliciclib (CYC202; r-roscovitine) in combination with cytotoxic agents in human uterine sarcoma cell lines.
  • Risinger JI et al: Microsatellite instability in gynecological sarcomas and in hMSH2 mutant uterine sarcoma cell lines defective in mismatch repair activity.
  • Zhu XQ et al: [Mast cells in cellular leiomyoma and endometrial stromal sarcoma of the uterus].
  • Vollmer G et al: Localization of tenascin in uterine sarcomas and partially transformed endometrial stromal cells.
  • Roomi MW et al: Anticancer effects of a specific mixture of nutrients in the multidrug-resistant human uterine sarcoma MES-SA/Dx5 and the drug-sensitive MES-SA cell lines.
  • Ma HB et al: Successful treatment of mast cell sarcoma of the uterus with imatinib.
  • Sanyal C: Stromal cell sarcoma of uterus in a teenaged girl.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706132852.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


26. |......... 3%  Cooper IF, Siadaty MS: 'Cells' associated with 'Cell Sarcoma Small': Top Publications. BioMedLib Review; Cell;CellSarcomaSmall:707054871. ISSN: 2331-5717. 2014/3/4
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Cells' associated with 'Cell Sarcoma Small': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Cell' for 'cell sarcoma small'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Cell'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 31 publications, and group two 2314 publications.
  • Here are the top 10.
  • Ito E et al: A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor.
  • Fraser CR et al: Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.
  • Hill DA et al: WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study.
  • Chen W et al: Langerhans Cell Sarcoma Arising from Chronic Lymphocytic Lymphoma/Small Lymphocytic Leukemia: Lineage Analysis and BRAF V600E Mutation Study.
  • Nakayama S et al: A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant.
  • Mahamid A et al: Small intestine perforation due to metastatic uterine cervix interdigitating dendritic cell sarcoma: a rare manifestation of a rare disease.
  • Yamada Y et al: Follicular dendritic cell sarcoma of small intestine with aberrant T-cell marker expression.
  • Venkataraman G et al: Clear cell sarcoma of the small bowel: a potential pitfall. Case report.
  • Bugalia A et al: Mast cell sarcoma of the small intestine: a case report.
  • Cossu A et al: Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 707054871.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


27. |......... 3%  Cooper IF, Siadaty MS: 'Neoplastic Processes' associated with 'Cell Sarcoma Small': Top Publications. BioMedLib Review; NeoplasticProcess;CellSarcomaSmall:707336133. ISSN: 2331-5717. 2014/7/8
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Neoplastic Processes' associated with 'Cell Sarcoma Small': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Neoplastic Process' for 'cell sarcoma small'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Neoplastic Process'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 46 publications, and group two 2917 publications.
  • Here are the top 10.
  • Cooper IF et al: 'Cells' associated with 'Small Cell Sarcoma Of Small Intestine': Top Publications.
  • Müller S et al: Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
  • Leenman EE et al: [Immunohistochemical study of small cell sarcomas and factors(nm23, CD44) predicting metastatic spreading in children].
  • Lee AF et al: FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
  • Venkataraman G et al: Clear cell sarcoma of the small bowel: a potential pitfall. Case report.
  • Yamada Y et al: Follicular dendritic cell sarcoma of small intestine with aberrant T-cell marker expression.
  • Hill DA et al: WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study.
  • Chen W et al: Langerhans Cell Sarcoma Arising from Chronic Lymphocytic Lymphoma/Small Lymphocytic Leukemia: Lineage Analysis and BRAF V600E Mutation Study.
  • Shao H et al: Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
  • Bugalia A et al: Mast cell sarcoma of the small intestine: a case report.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 707336133.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


28. |......... 3%  Cooper IF, Siadaty MS: 'Quantitative Concepts' associated with 'Cell Sarcoma Small': Top Publications. BioMedLib Review; QuantitativeConcept;CellSarcomaSmall:706354080. ISSN: 2331-5717. 2014/7/26
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Quantitative Concepts' associated with 'Cell Sarcoma Small': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Quantitative Concept' for 'cell sarcoma small'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Quantitative Concept'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 19 publications, and group two 1303 publications.
  • Here are the top 10.
  • Cooper IF et al: 'Steroids' associated with 'Cell Sarcoma Small': Top Publications.
  • Zhu H et al: Radiation-induced sarcoma in bronchial stump after thoracic radiation therapy for small-cell lung cancer.
  • Nakayama S et al: A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant.
  • Mahamid A et al: Small intestine perforation due to metastatic uterine cervix interdigitating dendritic cell sarcoma: a rare manifestation of a rare disease.
  • Shao H et al: Clonally related histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a study of seven cases.
  • Subbiah V et al: Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).
  • Lee AF et al: FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma.
  • Bugalia A et al: Mast cell sarcoma of the small intestine: a case report.
  • Wang E et al: Histiocytic sarcoma arising in indolent small B-cell lymphoma: report of two cases with molecular/genetic evidence suggestive of a 'transdifferentiation' during the clonal evolution.
  • Machado I et al: Galectin-1 (GAL-1) expression is a useful tool to differentiate between small cell osteosarcoma and Ewing sarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706354080.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


29. |......... 3%  Cooper IF, Siadaty MS: 'Steroids' associated with 'Cell Sarcoma Small': Top Publications. BioMedLib Review; Steroid;CellSarcomaSmall:705678565. ISSN: 2331-5717. 2014/6/26
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Steroids' associated with 'Cell Sarcoma Small': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Steroid' for 'cell sarcoma small'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Steroid'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 21 publications, and group two 3208 publications.
  • Here are the top 10.
  • Müller S et al: Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
  • Fraser CR et al: Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.
  • Nakayama S et al: A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant.
  • Terazawa K et al: Clear-cell sarcoma of the small intestine detected by FDG-PET/CT during comprehensive examination of an inflammatory reaction.
  • Subbiah V et al: Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).
  • Ito E et al: A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor.
  • Glaser J et al: [Small-cell sarcoma of the esophagus as a fourth malignancy. Its palliative therapy with argon gas coagulation].
  • Venkataraman G et al: Clear cell sarcoma of the small bowel: a potential pitfall. Case report.
  • Bugalia A et al: Mast cell sarcoma of the small intestine: a case report.
  • Park SH et al: Small cell osteogenic sarcoma of the ribs: cytological, immunohistochemical, and ultrastructural study with literature review.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705678565.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


30. |......... 3%  Cooper IF, Siadaty MS: 'Cells' associated with 'Rat Sarcoma': Top Publications. BioMedLib Review; Cell;RatSarcoma:706967643. ISSN: 2331-5717. 2014/12/3
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Cells' associated with 'Rat Sarcoma': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Cell' for 'rat sarcoma'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Cell'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 26 publications, and group two 1735 publications.
  • Here are the top 10.
  • Honoki K et al: Comparison of gene expression profiling in sarcomas and mesenchymal stem cells identifies tumorigenic pathways in chemically induced rat sarcoma model.
  • Remedi MM et al: Polymorphonuclear cells stimulate the migration and metastatic potential of rat sarcoma cells.
  • Fincham VJ et al: On the structure, genesis and significance of DNA duplications at the Rous sarcoma proviral insertion sites in Rat-1 cells.
  • Umezawa K et al: Induction of morphological change by tyrosine kinase inhibitors in Rous sarcoma virus-transformed rat kidney cells.
  • Baselmans AH et al: Brief communication, Histopathology of a spontaneously developing mast cell sarcoma in a Wistar rat.
  • Umenishi F et al: Purification and properties of extracellular matrix-degrading metallo-proteinase overproduced by Rous sarcoma virus-transformed rat liver cell line, and its identification as transin.
  • Holubova M et al: Characterization of three newly established rat sarcoma cell clones.
  • Polianova MT et al: Expression of V-SRC and chromosome analysis of a newly established cell line from rat sarcoma induced by an avian retroviral strain.
  • Yamate J et al: Establishment and characterization of transplantable tumor line (KB) and cell lines (KB-P and KB-D8) from a rat thymus-derived dendritic cell sarcoma.
  • Sandler B et al: Expression of p53 protein in rat colon cancer cell lines transfected with Rous sarcoma virus-33.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706967643.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


31. |......... 2%  Cooper IF, Siadaty MS: 'Neoplastic Processes' associated with 'Cutaneous Mastocytoses': Top Publications. BioMedLib Review; NeoplasticProcess;CutaneousMastocytoses:706844604. ISSN: 2331-5717. 2014/8/1
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Neoplastic Processes' associated with 'Cutaneous Mastocytoses': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Neoplastic Process' for 'cutaneous mastocytoses'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Neoplastic Process'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 16 publications, and group two 206602 publications.
  • Here are the top 9.
  • Gutiérrez-González E et al: Letter: Cutaneous mastocytosis with systemic involvement mimicking clinical and dermatoscopically multiple melanocytic nevi.
  • Vannorsdall EJ et al: Symptomatic response to imatinib mesylate in cutaneous mastocytosis associated with chronic myelomonocytic leukemia.
  • Lamm CG et al: Disseminated cutaneous mast cell tumors with epitheliotropism and systemic mastocytosis in a domestic cat.
  • Auquit-Auckbur I et al: Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
  • Miyagawa S et al: Cutaneous mastocytosis associated with a mixed germ cell tumour of the ovary: report of a case and review of the literature.
  • Shaw DW et al: Generalized cutaneous mastocytosis and acute myelogenous leukemia.
  • Chizhova ZP: [Pigmented urticaria (benign reticulosis of the skin of mastocytosis type].
  • Chantorn R et al: Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.
  • Kowalzic L et al: Telangiectasia macularis eruptiva perstans, a form of cutaneous mastocytosis, associated with malignant melanoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706844604.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


32. |......... 2%  Cooper IF, Siadaty MS: 'Neoplastic Processes' associated with 'Mastocytoma Diagnosis': Top Publications. BioMedLib Review; NeoplasticProcess;MastocytomaDiagnosis:706408311. ISSN: 2331-5717. 2014/8/26
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Neoplastic Processes' associated with 'Mastocytoma Diagnosis': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Neoplastic Process' for 'mastocytoma diagnosis'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Neoplastic Process'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 23 publications, and group two 409 publications.
  • Here are the top 10.
  • Cooper IF et al: 'Carbohydrates' associated with 'Mastocytoma Diagnosis': Top Publications.
  • Auquit-Auckbur I et al: Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
  • Naysan J et al: Solitary mastocytoma of the eyelid.
  • Ma D et al: Identification of KIT activating mutations in paediatric solitary mastocytoma.
  • Mroz P et al: Photodynamic therapy of murine mastocytoma induces specific immune responses against the cancer/testis antigen P1A.
  • Velusamy S et al: Solitary mastocytoma of the vulva.
  • Hosseini E et al: Cutaneous mast cell tumor (Mastocytoma): cyto- histopathological and haematological investigations.
  • Abdullah L et al: Dermacase: Can you identify this condition? Solitary mastocytoma.
  • Pérez-Elizondo AD et al: [Cutaneous mastocytoma: A brief literature review and report of two cases].
  • Maxová H et al: Growth of vascular smooth muscle cells on collagen I exposed to RBL-2H3 mastocytoma cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706408311.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


33. |......... 2%  Cooper IF, Siadaty MS: 'Diseases or Syndromes' associated with 'Mastocytoma Diagnosis': Top Publications. BioMedLib Review; DiseaseOrSyndrome;MastocytomaDiagnosis:706397648. ISSN: 2331-5717. 2014/12/26
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Diseases or Syndromes' associated with 'Mastocytoma Diagnosis': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Disease or Syndrome' for 'mastocytoma diagnosis'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Disease or Syndrome'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 21 publications, and group two 2990 publications.
  • Here are the top 10.
  • Targowski S: Determination of immune complexes in sera from dogs with various diseases by mastocytoma cell assay.
  • Yee SB et al: zVAD-fmk, unlike BocD-fmk, does not inhibit caspase-6 acting on 14-3-3/Bad pathway in apoptosis of p815 mastocytoma cells.
  • Auquit-Auckbur I et al: Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
  • Barr MC et al: Spinal lymphosarcoma and disseminated mastocytoma associated with feline immunodeficiency virus infection in a cat.
  • Tran DT et al: Histiocyte-rich pleomorphic mastocytoma: an uncommon variant mimicking juvenile xanthogranuloma and Langerhans cell histiocytosis.
  • Nishio M et al: [A case of mastocytoma associated with disseminated intravascular coagulation (DIC)].
  • Matsumoto M et al: Plane xanthoma associated with multiple mastocytoma.
  • Forsberg LS et al: Dog mastocytoma proteoglycans: occurrence of heparin and oversulfated chondroitin sulfates, containing trisulfated disaccharides, in three cell lines.
  • Castells MC: Extracutaneous mastocytoma.
  • Medvedev AE et al: [Humoral mechanisms of the membrano-toxic effects of mastocytoma P815 and leukemia EL4 cells].

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 706397648.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


34. |......... 2%  Cooper IF, Siadaty MS: 'Mental Processes' associated with 'Basophilic Histiocyte': Top Publications. BioMedLib Review; MentalProcess;BasophilicHistiocyte:707313917. ISSN: 2331-5717. 2014/5/8
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Mental Processes' associated with 'Basophilic Histiocyte': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Mental Process' for 'basophilic histiocyte'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Mental Process'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 41 publications, and group two 9790 publications.
  • Here are the top 10.
  • Jennings S et al: The Mastocytosis Society survey on mast cell disorders: patient experiences and perceptions.
  • Fitzgerald JJ et al: Evidence for the role of mast cells in colon-bladder cross organ sensitization.
  • Zhang S et al: Role of prostaglandin D2 in mast cell activation-induced sensitization of esophageal vagal afferents.
  • Li H et al: [Roles of cardiac mast cells and Toll-like receptor 4 in viral myocarditis among mice].
  • Ryan RJ et al: Mast cell sarcoma: a rare and potentially under-recognized diagnostic entity with specific therapeutic implications.
  • Gan X et al: The mechanism of sevoflurane preconditioning-induced protections against small intestinal ischemia reperfusion injury is independent of mast cell in rats.
  • Cao Z et al: [Pattern recognition and activation effect of mast cells in vitro infected by Brucella suis S2].
  • Fukuda M et al: Expression and functional characterization of retinoic acid-inducible gene-I-like receptors of mast cells in response to viral infection.
  • Silver R et al: Mast cells on the mind: new insights and opportunities.
  • Mori T et al: D1-like dopamine receptors antagonist inhibits cutaneous immune reactions mediated by Th2 and mast cells.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 707313917.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


35. |......... 2%  Cooper IF, Siadaty MS: 'Neoplastic Processes' associated with 'Localized Cutaneous Mastocytosis': Top Publications. BioMedLib Review; NeoplasticProcess;LocalizedCutaneousMastocytosis:707418477. ISSN: 2331-5717. 2014/1/10
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Neoplastic Processes' associated with 'Localized Cutaneous Mastocytosis': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Neoplastic Process' for 'localized cutaneous mastocytosis'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Neoplastic Process'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 38 publications, and group two 1023 publications.
  • Here are the top 10.
  • Tschandl P et al: Systemic mastocytosis associated with chronic myelomonocytic leukemia and xanthogranuloma.
  • Zhrebker L et al: Systemic mastocytosis with associated acute myelogenous leukemia.
  • Bibi S et al: Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.
  • Cooper IF et al: 'Neoplastic Processes' associated with 'M Malignant Mastocytosis': Top Publications.
  • Gadage VS et al: Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22).
  • Vannorsdall EJ et al: Symptomatic response to imatinib mesylate in cutaneous mastocytosis associated with chronic myelomonocytic leukemia.
  • Chantorn R et al: Death from mast cell leukemia: a young patient with longstanding cutaneous mastocytosis evolving into fatal mast cell leukemia.
  • Johnson RC et al: Hidden mastocytosis in acute myeloid leukemia with t(8;21)(q22;q22).
  • Won D et al: The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients.
  • Auquit-Auckbur I et al: Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 707418477.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


36. |......... 2%  Cooper IF, Siadaty MS: 'Cells' associated with 'Clinical Management': Top Publications. BioMedLib Review; Cell;ClinicalManagement:705803291. ISSN: 2331-5717. 2014/1/20
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Cells' associated with 'Clinical Management': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Cell' for 'clinical management'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Cell'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 35 publications, and group two 15975 publications.
  • Here are the top 10.
  • Thakuria M et al: Update on the biology and clinical management of Merkel cell carcinoma.
  • Peveling-Oberhag J et al: Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
  • Goyal L: Clinical effectiveness of combining platelet rich fibrin with alloplastic bone substitute for the management of combined endodontic periodontal lesion.
  • Dourmishev LA et al: Clinical variants, stages, and management of basal cell carcinoma.
  • Zhu Y et al: Clinical efficacy and safety of imatinib in the management of Ph(+) chronic myeloid or acute lymphoblastic leukemia in Chinese patients.
  • Krzemieniecki K et al: Neutropenia management and granulocyte colony-stimulating factor use in patients with solid tumours receiving myelotoxic chemotherapy--findings from clinical practice.
  • Ribeiro IP et al: Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.
  • Weiler CR et al: Mast cell sarcoma: clinical management.
  • Shuch B et al: Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
  • Agochukwu N et al: Clinical management of renal cell carcinoma with venous tumor thrombus.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705803291.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


37. |......... 2%  Cooper IF, Siadaty MS: 'Hormones' associated with 'Cell Sarcoma Small': Top Publications. BioMedLib Review; Hormone;CellSarcomaSmall:705150799. ISSN: 2331-5717. 2014/11/25
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Hormones' associated with 'Cell Sarcoma Small': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Hormone' for 'cell sarcoma small'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Hormone'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 22 publications, and group two 3218 publications.
  • Here are the top 10.
  • Müller S et al: Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
  • Fraser CR et al: Transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma to interdigitating dendritic cell sarcoma: evidence for transdifferentiation of the lymphoma clone.
  • Nakayama S et al: A rare case of primary clear cell sarcoma of the pubic bone resembling small round cell tumor: an unusual morphological variant.
  • Terazawa K et al: Clear-cell sarcoma of the small intestine detected by FDG-PET/CT during comprehensive examination of an inflammatory reaction.
  • Subbiah V et al: Morphoproteomic profiling of the mammalian target of rapamycin (mTOR) signaling pathway in desmoplastic small round cell tumor (EWS/WT1), Ewing's sarcoma (EWS/FLI1) and Wilms' tumor(WT1).
  • Ito E et al: A tetraspanin-family protein, T-cell acute lymphoblastic leukemia-associated antigen 1, is induced by the Ewing's sarcoma-Wilms' tumor 1 fusion protein of desmoplastic small round-cell tumor.
  • Glaser J et al: [Small-cell sarcoma of the esophagus as a fourth malignancy. Its palliative therapy with argon gas coagulation].
  • Venkataraman G et al: Clear cell sarcoma of the small bowel: a potential pitfall. Case report.
  • Bugalia A et al: Mast cell sarcoma of the small intestine: a case report.
  • Choi EY et al: Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705150799.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


38. |......... 2%  Cooper IF, Siadaty MS: 'Cells' associated with 'Cutaneous Mastocytoses': Top Publications. BioMedLib Review; Cell;CutaneousMastocytoses:707023412. ISSN: 2331-5717. 2014/2/4
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Cells' associated with 'Cutaneous Mastocytoses': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Cell' for 'cutaneous mastocytoses'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Cell'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 25 publications, and group two 81068 publications.
  • Here are the top 10.
  • Longley BJ Jr et al: Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis.
  • Idoate MA et al: Expression of the basophil-specific antibodies 2D7 and BB1 in patients with cutaneous Mastocytosis.
  • Krilis SA et al: Continuous release of secretory granule proteoglycans from a cell strain derived from the bone marrow of a patient with diffuse cutaneous mastocytosis.
  • Kunisada T et al: Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor.
  • Krilis SA et al: Establishment in culture and characterization of a strain with mast cell and monocytic properties from the bone marrow of a child with diffuse cutaneous mastocytosis.
  • Tang X et al: A germline mutation in KIT in familial diffuse cutaneous mastocytosis.
  • Auquit-Auckbur I et al: Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma.
  • Akiyama M et al: Immunohistochemical characterization of human cutaneous mast cells in urticaria pigmentosa (cutaneous mastocytosis).
  • Hartmann K et al: Evidence for altered mast cell proliferation and apoptosis in cutaneous mastocytosis.
  • Wang HJ et al: A new germline mutation in KIT associated with diffuse cutaneous mastocytosis in a Chinese family.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 707023412.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


39. |......... 2%  Cooper IF, Siadaty MS: 'Cells' associated with 'Ac Ascending Colon': Top Publications. BioMedLib Review; Cell;AcAscendingColon:705734776. ISSN: 2331-5717. 2014/5/27
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Cells' associated with 'Ac Ascending Colon': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Cell' for 'ac ascending colon'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Cell'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 21 publications, and group two 926 publications.
  • Here are the top 10.
  • Beyer K et al: TRAIL induces neutrophil apoptosis and dampens sepsis-induced organ injury in murine colon ascendens stent peritonitis.
  • Okishio Y et al: Ascending contraction and descending relaxation in the distal colon of mice lacking interstitial cells of Cajal.
  • Barbaryan A et al: Primary diffuse large B-cell lymphoma of the ascending colon.
  • Spencer N et al: Sympathetic inhibition of ascending and descending interneurones during the peristaltic reflex in the isolated guinea-pig distal colon.
  • Udhreja PR et al: T-cell/histiocyte rich B-cell lymphoma of mass in caecum and part of ascending colon.
  • Kim YN et al: Concurrent large cell neuroendocrine carcinoma and adenocarcinoma of the ascending colon: a case report.
  • Yamanashi T et al: [A case of endocrine cell carcinoma of the ascending colon with liver metastasis treated with hepatectomy after excision of the primary lesion and systemic chemotherapy].
  • Uriev L et al: Signet ring cell infiltration in tubular adenoma of ascending colon.
  • Kojima M et al: Mast cell sarcoma with tissue eosinophilia arising in the ascending colon.
  • Moriwaki Y et al: [A case of neuroendocrine cell carcinoma of the ascending colon].

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 705734776.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


40. |......... 2%  Cooper IF, Siadaty MS: 'Functional Concepts' associated with 'First Sign': Top Publications. BioMedLib Review; FunctionalConcept;FirstSign:707226955. ISSN: 2331-5717. 2014/8/7
PDF icon [Fulltext service] Download fulltext PDF of this article.

  • [Title] 'Functional Concepts' associated with 'First Sign': Top Publications.
  • [Transliterated title]
  • Background: There are articles published each month which present 'Functional Concept' for 'first sign'.
  • Finding such articles is important for researchers, clinicians, and patients.
  • However these articles are spread across thousands of journals, and there are many types of 'Functional Concept'.
  • This makes searching and locating the relevant publications a challenge.
  • We have used BioMedLib's semantic search technology to address the issue, and gathered all the pertinent publications in this review article.
  • Methods: We categorized the publications we found into two groups.
  • We used the strength of textual-association to separate the groups.
  • In group one there are publications with the strongest evidence of association. We focused finding the most relevant publications pertinent to our goal, rather than combining them into a conclusion section. Such textual synthesis will be the focus of our next project.
  • Results: Group one includes 32 publications, and group two 3796 publications.
  • Here are the top 10.
  • Kaźmierczak E et al: Exudative pericarditis in a pregnant woman as the first sign of non-Hodgkin's lymphoma.
  • Melo DH et al: [Choroidal metastasis of gastric adenocarcinoma as a first sign of systemic disease recurrence: case report].
  • Eckardt AM et al: Orbital metastases as first sign of metastatic spread in breast cancer: case report and review of the literature.
  • Sechi A et al: Myocardial fibrosis as the first sign of cardiac involvement in a male patient with Fabry disease: report of a clinical case and discussion on the utility of the magnetic resonance in Fabry pathology.
  • Milber JM et al: Lewy pathology is not the first sign of degeneration in vulnerable neurons in Parkinson disease.
  • Ariizumi Y et al: Chorea as the first sign in a patient with elderly-onset systemic lupus erythematosus.
  • Mavrogeni S et al: Myopericarditis, as the first sign of rheumatoid arthritis relapse, evaluated by cardiac magnetic resonance.
  • Falleti J et al: Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis?.
  • Zuffa M: [Paraneoplastic thromboembolic syndrome as the first sign of a malignant disease].
  • Grandić L et al: Atypical non-small cell lung cancer presentation: inguinal lymph node metastases as the first sign of disease relapse.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2014 Siadaty and Cooper; licensee BioMedLib LLC.
  • (UID = 707226955.001).
  • [ISSN] 2331-5717
  • [Journal-full-title] BioMedLib Review
  • [Language] eng
  • [Publication-type] Review
  • [Publication-country] UNITED STATES
  •  go-up   go-down


41. |......... 2%  Hume CT, Kiupel M, Rigatti L, Shofer FS, Skorupski KA, Sorenmo KU: Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007). J Am Anim Hosp Assoc; 2011 Jan-Feb;47(1):37-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Outcomes of dogs with grade 3 mast cell tumors: 43 cases (1997-2007).
  • This study reports the outcomes of dogs with grade 3 mast cell tumors (MCTs).
  • Clinical and histopathological data were available for 43 dogs.
  • Tumor size, lymph node (LN) status, and mitotic index (MI) significantly influenced PFS in univariate analysis.
  • Tumor size and LN status remained significant in the multivariate analysis.
  • Lymph node status, local tumor control, LN treatment, and MI significantly influenced OS in univariate analysis but only LN status remained significant in multivariate analysis.
  • These results confirm that locoregional control improves outcomes in patients with grade 3 MCTs.
  • [MeSH-major] Dog Diseases / mortality. Mast-Cell Sarcoma / veterinary
  • [MeSH-minor] Animals. Disease-Free Survival. Dogs. Female. Immunohistochemistry / veterinary. Kaplan-Meier Estimate. Lymphatic Metastasis. Male. Mitotic Index. Multivariate Analysis. Neoplasm Staging / veterinary. Retrospective Studies. Treatment Outcome

  • COS Scholar Universe. author profiles.
  • ExactAntigen/Labome. author profiles.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21164163.001).
  • [ISSN] 1547-3317
  • [Journal-full-title] Journal of the American Animal Hospital Association
  • [ISO-abbreviation] J Am Anim Hosp Assoc
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


42. |......... 2%  Hahn KA, Legendre AM, Shaw NG, Phillips B, Ogilvie GK, Prescott DM, Atwater SW, Carreras JK, Lana SE, Ladue T, Rusk A, Kinet JP, Dubreuil P, Moussy A, Hermine O: Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors. Am J Vet Res; 2010 Nov;71(11):1354-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.
  • OBJECTIVE: To evaluate the effectiveness of masitinib for the treatment of nonresectable mast cell tumors (MCTs) in dogs at 12 and 24 months after onset of treatment.
  • After 6 months, treatment was extended with tumor assessments at 3-month intervals until detection of disease progression.
  • Endpoints were tumor response and overall survival rate and time.
  • Tumor control at 6 months had a high predictive value for 24-month survival, with high specificity (88%) and sensitivity (76%), whereas short-term tumor response (within 6 weeks) had a poor predictive value.
  • CONCLUSIONS AND CLINICAL RELEVANCE: Masitinib significantly increased survival rates at 12 and 24 months in dogs with nonresectable MCTs.
  • Control of disease at 6 months, but not best response at 6 weeks, was predictive of long-term survival in dogs treated with masitinib, which suggested that short-term response may be irrelevant for assessing clinical efficacy of tyrosine kinase inhibitors for treatment of MCTs.
  • [MeSH-major] Antineoplastic Agents / therapeutic use. Mast-Cell Sarcoma / veterinary

  • MedlinePlus Health Information. consumer health - Cancer Chemotherapy.
  • ExactAntigen/Labome. author profiles.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Am J Vet Res. 2011 Feb;72(2):247
  • (PMID = 21034327.001).
  • [ISSN] 0002-9645
  • [Journal-full-title] American journal of veterinary research
  • [ISO-abbreviation] Am. J. Vet. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; 0 / Thiazoles; M59NC4E26P / masitinib
  •  go-up   go-down


43. |......... 2%  Book AP, Fidel J, Wills T, Bryan J, Sellon R, Mattoon J: Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors. Vet Radiol Ultrasound; 2011 Sep-Oct;52(5):548-54
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Correlation of ultrasound findings, liver and spleen cytology, and prognosis in the clinical staging of high metastatic risk canine mast cell tumors.
  • Cytologic sampling of the ultrasonographically normal spleen and liver is not implemented routinely in the clinical staging of canine cutaneous mast cell tumors and normal ultrasound findings are often accepted as sufficient evidence for ruling out splenic or liver metastasis.
  • Our objective was to define the specificity and sensitivity of ultrasound findings for diagnosis of mast cell infiltration when verified with cytologic evaluation, and to define the prognostic role of cytologic evaluation of liver and splenic aspirates.
  • Dogs with a diagnosis of clinically aggressive grade II, or grade III mast cell tumor treated with a combination vinblastine/CCNU chemotherapy protocol, were selected retrospectively based on availability of cytologic evaluation of spleen plus or minus liver for staging.
  • Out of 19 dogs, 10 dogs had a grade II tumor and nine a grade III tumor.
  • Seven dogs had mast cell infiltration of the spleen, liver, or both.
  • The sensitivity of ultrasound for detecting mast cell infiltration was 43% for the spleen and 0% for the liver.
  • Dogs with positive cytologic evidence of mast cell infiltration to spleen, liver, or both had significantly shorter survival (100 vs. 291 days) than dogs without evidence of mast cell infiltration (P<0.0001).
  • Routine splenic aspiration should be performed regardless of ultrasonographic appearance in dogs with a clinically aggressive mast cell tumor.
  • [MeSH-major] Dog Diseases / ultrasonography. Mast-Cell Sarcoma / secondary. Mast-Cell Sarcoma / veterinary. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2011 Veterinary Radiology & Ultrasound.
  • (PMID = 21689203.001).
  • [ISSN] 1058-8183
  • [Journal-full-title] Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association
  • [ISO-abbreviation] Vet Radiol Ultrasound
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. |......... 2%  Stefanello D, Valenti P, Faverzani S, Bronzo V, Fiorbianco V, Pinto da Cunha N, Romussi S, Cantatore M, Caniatti M: Ultrasound-guided cytology of spleen and liver: a prognostic tool in canine cutaneous mast cell tumor. J Vet Intern Med; 2009 Sep-Oct;23(5):1051-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ultrasound-guided cytology of spleen and liver: a prognostic tool in canine cutaneous mast cell tumor.
  • BACKGROUND: In the clinical staging of cutaneous mast cell tumors (cMCT), the diagnosis of metastasis is controversial based on cytological examination of lymph nodes, spleen, liver, bone marrow, and blood.
  • ANIMALS: Fifty-two client-owned dogs with a diagnosis of cMCT.
  • RESULTS: Ten dogs with cMCT had mast cell infiltration of spleen, liver, or both and 4 of these dogs had involvement of the regional lymph nodes.
  • Dogs with positive evidence of mast cell infiltration to spleen, liver, or both had shorter survival times (34 versus 733 days) compared with dogs negative for mast cell infiltration at distant sites.
  • CONCLUSION AND CLINICAL IMPORTANCE: Dogs with evidence of mast cell infiltration at distant sites have a shorter survival times than dogs without evidence of infiltration at distant sites.
  • [MeSH-major] Dog Diseases / ultrasonography. Mast-Cell Sarcoma / veterinary. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • ExactAntigen/Labome. author profiles.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19656285.001).
  • [ISSN] 0891-6640
  • [Journal-full-title] Journal of veterinary internal medicine / American College of Veterinary Internal Medicine
  • [ISO-abbreviation] J. Vet. Intern. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


45. |......... 2%  Nagamine MK, Sanches DS, Pinello KC, Torres LN, Mennecier G, Latorre AO, Fukumasu H, Dagli ML: In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor. Vet Res Commun; 2011 Aug;35(6):391-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] In vitro inhibitory effect of trichostatin A on canine grade 3 mast cell tumor.
  • Mast cell tumor (MCT) is one of the most prevalent neoplasms that affect skin and soft tissue in dogs.
  • Because mast cell tumors present a great variety of clinical appearance and behavior, their treatment becomes a challenge.
  • MTT assay and trypan blue exclusion assays were performed to estimate cell growth and cell viability, and cell cycle analysis was evaluated.
  • TSA treatment showed a reduction in numbers of viable cells and an increase of cell death by apoptosis.
  • The cell cycle analysis showed an increase of hypodiploid cells and a reduction of G0/G1 and G2/M -phases.
  • [MeSH-major] Histone Deacetylase Inhibitors / pharmacology. Hydroxamic Acids / pharmacology. Mast-Cell Sarcoma / veterinary
  • [MeSH-minor] Acetylation. Animals. Apoptosis / drug effects. Cell Line, Tumor. Cell Proliferation / drug effects. Cell Survival / drug effects. Dogs. Female. Histones / metabolism. Mice. Mice, Nude. Tetrazolium Salts / chemistry. Thiazoles / chemistry. Trypan Blue / chemistry

  • HSDB. structure - METHYLTHIAZOLETETRAZOLIUM.
  • HSDB. structure - TRYPAN BLUE.
  • ResearchGate. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21472452.001).
  • [ISSN] 1573-7446
  • [Journal-full-title] Veterinary research communications
  • [ISO-abbreviation] Vet. Res. Commun.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Histone Deacetylase Inhibitors; 0 / Histones; 0 / Hydroxamic Acids; 0 / Tetrazolium Salts; 0 / Thiazoles; 298-93-1 / thiazolyl blue; 3X2S926L3Z / trichostatin A; I2ZWO3LS3M / Trypan Blue
  •  go-up   go-down


46. |......... 1%  Taylor F, Gear R, Hoather T, Dobson J: Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases. J Small Anim Pract; 2009 Jun;50(6):284-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chlorambucil and prednisolone chemotherapy for dogs with inoperable mast cell tumours: 21 cases.
  • OBJECTIVES: To evaluate the response of measurable canine mast cell tumours unsuitable for other treatment modalities to a chemotherapy protocol comprising chlorambucil and prednisolone.
  • METHODS: Dogs bearing measurable mast cell tumours, unsuitable for treatment by surgery or radiotherapy, were treated with orally administered prednisolone and chlorambucil, and their responses assessed.
  • RESULTS: Twenty-one dogs were enrolled in the study; 13 had intermediate-grade mast cell tumour, six were high grade and two were diagnosed by cytology alone.
  • Eight dogs had multiple tumours and 13 dogs had single tumours, and six dogs had lymph node metastases and no dogs had visceral metastases detected.
  • Three dogs achieved complete remission, five achieved partial remission (overall response rate 38 per cent), nine had static disease and four dogs had progressive disease.
  • Progression-free interval and median survival time were not influenced by the age, sex, weight or neutering status of the patient, by the grade or stage of the tumour or whether the patient had single or multiple tumours.
  • CLINICAL SIGNIFICANCE: Response and survival rates of inoperable canine MCT to chlorambucil and prednisolone are comparable to previously described protocols, with no apparent toxicity.
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Dog Diseases / drug therapy. Mast-Cell Sarcoma / veterinary. Skin Neoplasms / veterinary
  • [MeSH-minor] Animals. Antineoplastic Agents, Alkylating / therapeutic use. Antineoplastic Agents, Hormonal / therapeutic use. Chlorambucil / therapeutic use. Disease Progression. Dogs. Female. Lymphatic Metastasis. Male. Neoplasm Staging / veterinary. Prednisolone / therapeutic use. Prospective Studies. Survival Analysis. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • HSDB. structure - CHLORAMBUCIL.
  • HSDB. structure - PREDNISOLONE.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19527421.001).
  • [ISSN] 1748-5827
  • [Journal-full-title] The Journal of small animal practice
  • [ISO-abbreviation] J Small Anim Pract
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 0 / Antineoplastic Agents, Hormonal; 18D0SL7309 / Chlorambucil; 9PHQ9Y1OLM / Prednisolone
  •  go-up   go-down


47. |......... 1%  Pokorny E, Hecht S, Sura PA, LeBlanc AK, Phillips J, Conklin GA, Haifley KA, Newkirk K: Magnetic resonance imaging of canine mast cell tumors. Vet Radiol Ultrasound; 2012 Mar-Apr;53(2):167-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Magnetic resonance imaging of canine mast cell tumors.
  • Mast cell tumors (MCT) are the most common cutaneous tumors in dogs.
  • The signal intensity of tumors and lymph nodes was compared to adjacent musculature.
  • All tumors were strongly contrast enhancing; 5/9 were homogeneous and 4/9 heterogeneous in their enhancement patterns.
  • MR imaging may be useful in the presurgical evaluation and clinical staging of cutaneous MCT.
  • [MeSH-major] Dog Diseases / diagnosis. Magnetic Resonance Imaging / veterinary. Mast-Cell Sarcoma / veterinary. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - MRI Scans.
  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 22136427.001).
  • [ISSN] 1058-8183
  • [Journal-full-title] Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association
  • [ISO-abbreviation] Vet Radiol Ultrasound
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. |......... 1%  Henry C, Herrera C: Mast cell tumors in cats: clinical update and possible new treatment avenues. J Feline Med Surg; 2013 Jan;15(1):41-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mast cell tumors in cats: clinical update and possible new treatment avenues.
  • PRACTICAL RELEVANCE: Feline mast cell tumors (MCTs) are frequently encountered in general practice.
  • MCTs are the most common splenic tumor, second most common skin tumor and third most common intestinal tumor in cats.
  • CLINICAL CHALLENGES: While a cytologic or histologic diagnosis is often easy to obtain, the various histologic classifications, lack of a relevant grading scheme, and disparity in behavior depending on anatomic location make prognostication for cases of feline MCTs confusing.
  • This is quite different from canine MCTs, where there is an established grading system which correlates clinically with prognosis and an accepted standard of care.
  • In many instances, referral for diagnosis and treatment is not necessary.
  • EVIDENCE BASE: Historically, there has been limited clinical evidence upon which to determine optimal treatment of MCTs in cats.
  • [MeSH-major] Cat Diseases / diagnosis. Cat Diseases / therapy. Mast-Cell Sarcoma / veterinary. Skin Neoplasms / veterinary

  • MedlinePlus Health Information. consumer health - Skin Cancer.
  • ExactAntigen/Labome. author profiles.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 23254240.001).
  • [ISSN] 1532-2750
  • [Journal-full-title] Journal of feline medicine and surgery
  • [ISO-abbreviation] J. Feline Med. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


49. |......... 1%  Taney K, Smith MM: Resection of mast cell tumor of the lip in a dog. J Vet Dent; 2009;26(1):28-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Resection of mast cell tumor of the lip in a dog.
  • A 10-year-old Boston terrier dog was presented for treatment of a 2-cm mast cell tumor of the left upper lip and nasal planum immediately adjacent to the philtrum and ventral to the nares.
  • [MeSH-major] Dog Diseases / surgery. Lip Neoplasms / veterinary. Mast-Cell Sarcoma / veterinary

  • ExactAntigen/Labome. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] J Vet Dent. 2009 Summer;26(2):120
  • (PMID = 19476085.001).
  • [ISSN] 0898-7564
  • [Journal-full-title] Journal of veterinary dentistry
  • [ISO-abbreviation] J Vet Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


50. |......... 1%  Spugnini EP, Vincenzi B, Citro G, Dotsinsky I, Mudrov T, Baldi A: Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs. J Vet Intern Med; 2011 Mar-Apr;25(2):407-11
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of Cisplatin as an electrochemotherapy agent for the treatment of incompletely excised mast cell tumors in dogs.
  • BACKGROUND: Electrochemotherapy (ECT) couples the administration of anticancer drugs with the delivery of electric pulses that increase the drug uptake through the cell membranes, resulting in an improved efficacy.
  • HYPOTHESIS: To evaluate the tolerability and efficacy of cisplatin (CDDP) as an ECT agent to prevent recurrence of incompletely resected mast cell tumors (MCTs).
  • After debulking, the tumor bed and margins were infiltrated with CDDP, and then exposed to trains of biphasic electrical pulses under sedation.
  • A second session was performed 1 or 2 weeks later based on clinical considerations.
  • Twenty-nine dogs had no evidence of recurrence over the 6-year study period, 6 had tumor recurrence, 1 died of multiple cutaneous MCTs, and 1 died of unrelated causes.
  • CONCLUSIONS AND CLINICAL IMPORTANCE: ECT with CDDP appears effective in the treatment of incompletely resected MCT in dogs and could be a useful addition to the current options based on its low cost, limited toxicity, and ease of administration.
  • [MeSH-major] Dog Diseases / drug therapy. Electrochemotherapy / veterinary. Mast-Cell Sarcoma / veterinary

  • HSDB. structure - CIS-DIAMINEDICHLOROPLATINUM.
  • ExactAntigen/Labome. author profiles.
  • ResearchGate. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2011 by the American College of Veterinary Internal Medicine.
  • (PMID = 21382075.001).
  • [ISSN] 1939-1676
  • [Journal-full-title] Journal of veterinary internal medicine / American College of Veterinary Internal Medicine
  • [ISO-abbreviation] J. Vet. Intern. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents; Q20Q21Q62J / Cisplatin
  •  go-up   go-down


top


2. Definitions


3. Related RMF webpages


terms of use | advertising programs | contact us
© 2014 RecentMedicalFindings


Connect with the


RMF


audience;




Post your ad here!